MAGELLAN HEALTH INC (MGLN) Stock Price & Overview

NASDAQ:MGLN

Current stock price

94.99
0 (0%)
At close:
94.99
0 (0%)
After Hours:

The current stock price of MGLN is 94.99 null. Today MGLN is down by 0%. In the past month the price increased by 0.58%. In the past year, price increased by 0.68%.

MGLN Key Statistics

52-Week Range82.94 - 99.355
Current MGLN stock price positioned within its 52-week range.
1-Month Range92.625 - 95.36
Current MGLN stock price positioned within its 1-month range.
Market Cap
2.459B
P/E
87.15
Fwd P/E
27.31
EPS (TTM)
1.09
Dividend Yield
N/A

MGLN Stock Performance

Today
0%
1 Week
+0.15%
1 Month
+0.58%
3 Months
+0.33%
Longer-term
6 Months +0.79%
1 Year +0.68%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

MGLN Stock Chart

MAGELLAN HEALTH INC / MGLN Daily stock chart

MGLN Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to MGLN. When comparing the yearly performance of all stocks, MGLN turns out to be only a medium performer in the overall market: it outperformed 49.92% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

MGLN Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to MGLN. While MGLN has a great health rating, its profitability is only average at the moment.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

MGLN Earnings

Next Earnings DateMar 4, 2022
Last Earnings DateN/A
PeriodQ3 / 2021
EPS Reported$0.03
Revenue Reported
EPS Surprise -92.05%
Revenue Surprise 1.87%

MGLN Forecast & Estimates

6 analysts have analysed MGLN and the average price target is 96.9 null. This implies a price increase of 2.01% is expected in the next year compared to the current price of 94.99.

For the next year, analysts expect an EPS growth of 11.05% and a revenue growth 8.27% for MGLN


Analysts
Analysts43.33
Price Target96.9 (2.01%)
EPS Next Y11.05%
Revenue Next Year8.27%

MGLN Groups

Sector & Classification

Index Membership

MGLN Financial Highlights

Over the last trailing twelve months MGLN reported a non-GAAP Earnings per Share(EPS) of 1.09. The EPS decreased by -67.07% compared to the year before.


Income Statements
Revenue(TTM)4.82B
Net Income(TTM)301.97M
Industry RankSector Rank
PM (TTM) 6.26%
ROA 9%
ROE 15.61%
Debt/Equity 0.27
Chartmill High Growth Momentum
EPS Q2Q%-62.5%
Sales Q2Q%7.18%
EPS 1Y (TTM)-67.07%
Revenue 1Y (TTM)6.52%

MGLN Ownership

Ownership
Inst Owners1.27%
Shares25.89M
Float25.90M
Ins Owners1.57%
Short Float %N/A
Short RatioN/A

About MGLN

Company Profile

MGLN logo image Magellan Health, Inc. engages in the business of healthcare management. The company is headquartered in Phoenix, Arizona and currently employs 9,000 full-time employees. The company went IPO on 2004-01-06. The firm provides managed care and pharmacy solutions for healthcare. The firm's segments include Healthcare, Pharmacy Management and Corporate. Its Healthcare includes carve-out management services for behavioral health, employee assistance plans (EAP) and other areas of specialty healthcare including diagnostic imaging, musculoskeletal management, cardiac and physical medicine. Its Pharmacy Management segment consists of products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Its Corporate segment consists of amounts not allocated to the Healthcare and Pharmacy Management segments. The firm provides services to health plans and other managed care organizations (MCOs), employers, labor unions, various military and governmental agencies and third party administrators (TPAs).

Company Info

IPO: 2004-01-06

MAGELLAN HEALTH INC

4801 E Washington St

Phoenix ARIZONA 85034 US

CEO: Kenneth J. Fasola

Employees: 9000

MGLN Company Website

Phone: 18006421716.0

MAGELLAN HEALTH INC / MGLN FAQ

Can you describe the business of MAGELLAN HEALTH INC?

Magellan Health, Inc. engages in the business of healthcare management. The company is headquartered in Phoenix, Arizona and currently employs 9,000 full-time employees. The company went IPO on 2004-01-06. The firm provides managed care and pharmacy solutions for healthcare. The firm's segments include Healthcare, Pharmacy Management and Corporate. Its Healthcare includes carve-out management services for behavioral health, employee assistance plans (EAP) and other areas of specialty healthcare including diagnostic imaging, musculoskeletal management, cardiac and physical medicine. Its Pharmacy Management segment consists of products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Its Corporate segment consists of amounts not allocated to the Healthcare and Pharmacy Management segments. The firm provides services to health plans and other managed care organizations (MCOs), employers, labor unions, various military and governmental agencies and third party administrators (TPAs).


Can you provide the latest stock price for MAGELLAN HEALTH INC?

The current stock price of MGLN is 94.99 null.


Does MAGELLAN HEALTH INC pay dividends?

MGLN does not pay a dividend.


What is the ChartMill technical and fundamental rating of MGLN stock?

MGLN has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Should I buy MGLN stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on MGLN.


Can you provide the market cap for MAGELLAN HEALTH INC?

MAGELLAN HEALTH INC (MGLN) has a market capitalization of 2.46B null. This makes MGLN a Mid Cap stock.


When does MAGELLAN HEALTH INC (MGLN) report earnings?

MAGELLAN HEALTH INC (MGLN) will report earnings on 2022-03-04, after the market close.